MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer (MIB)
Magnetic Resonance Imaging of Bladder Cancer
Sponsor: Turku University Hospital
Listed as NCT02662166, this NA trial focuses on Bladder Cancer and remains completed. Sponsored by Turku University Hospital, it has been updated 9 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jul 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
May 2020 — Jul 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jun 2018 — May 2020 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Feb 2018 — May 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Turku University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .